May 25, 2021 | Federal Issues, Medicare Part D
By Surabhi Dangi-Garimella, PhD Opinions vary on the impact H.R.3 would have on patients and the U.S. health care system as a whole, depending on who you ask. Some of the changes proposed by H.R.3 are directed to redesign the Medicare Part D prescription drug...
Read more
May 10, 2021 | Featured, Federal Issues, Podcast
On this episode of the podcast, Terry and Bob discuss the threats posed by H.R. 3, prescription drug price control legislation that was reintroduced in the House of Representatives in April. They point out how the Covid-19 vaccine demonstrates the importance of...
Read more
Apr 22, 2021 | Press Releases
April 22, 2021 Contact: Summer Johnson Sjohnson@riesterpublicaffairs.com 202.421.9216 PATIENTS RISING STATEMENT ON H.R.3 WASHINGTON, DC — Terry Wilcox, Executive Director of Patients Rising, today released the following statement in response to today’s introduction...
Read more
